Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Prelude Therapeutics Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 53 | 60 | +7 |
| Shares | 31.8M | 31.2M | −643.3K (−2.0%) |
| Value | $210.3M | $188.3M | −$22.0M (−10.5%) |
New holders (12)
Institutions that held Prelude Therapeutics Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 683 Capital Management, LLC | 28,631 | $172.9K | 0.02% |
| Bleakley Financial Group, LLC | 22,325 | $134.8K | 0.00% |
| Man Group plc | 20,994 | $126.8K | 0.00% |
| Boothbay Fund Management, LLC | 17,623 | $106.4K | 0.00% |
| Jane Street Group, LLC | 16,807 | $101.5K | 0.00% |
| Mirabella Financial Services LLP | 16,058 | $97.0K | 0.01% |
| Qube Research & Technologies Ltd | 13,127 | $79.3K | 0.00% |
| Dark Forest Capital Management LP | 3,092 | $18.7K | 0.00% |
| Rockefeller Capital Management L.P. | 2,512 | $15.0K | 0.00% |
| Cutler Group LP | 2,130 | $12.0K | 0.00% |
| Bessemer Group Inc | 89 | $1.00K | 0.00% |
| FNY Investment Advisers, LLC | 200 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Prelude Therapeutics Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 583,333 | $3.86M |
| Virtus ETF Advisers LLC | 24,180 | $160.0K |
| PDT Partners, LLC | 12,641 | $84.0K |
| Simplex Trading, LLC | 470 | $3.00K |
| Capital Advisors, Ltd. LLC | 33 | $0 |